Displaying 1 - 5 of 5 tests
PD-L1 SP142 FDA (TECENTRIQ®) for Urothelial Carcinoma The VENTANA PD-L1 (SP142) Assay is a qualitative immunohistochemical assay using rabbit monoclonal anti-PD-L1 clone SP142 intended for use in the assessment of the PD-L1 protein in formalin-fixed,…
Immunohistochemistry (IHC)
PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC The VENTANA PD-L1 (SP142) Assay is a qualitative immunohistochemical assay using rabbit monoclonal anti-PD-L1 clone SP142 intended for use in the assessment of the PD-L1 protein in formalin-fixed,…
Immunohistochemistry (IHC)
PD-L1 SP142 FDA (TECENTRIQ®) for TNBC (Breast) The VENTANA PD-L1 (SP142) Assay is a qualitative immunohistochemical assay using rabbit monoclonal anti-PD-L1 clone SP142 intended for use in the assessment of the PD-L1 protein in formalin-fixed,…
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head & Neck) PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1, Clone 22C3 intended for use in the detection of PD-L1 protein in formalin-fixed, paraffin-embedded…
Immunohistochemistry (IHC)
NeoTYPE® Discovery Profile for Solid Tumors The NeoTYPE Discovery Profile analyzes 336 biomarkers through a combination of next-generation sequencing (NGS), FISH, and IHC as listed below. Test orders include summary interpretation of all…
Molecular